CpG DNA has immunomodulatory effects, such as the suppression of allergic responses mediated by type II T cell help (TH2). Here we report that CpG, but not lipopolysaccharide (LPS), rapidly induces expression of T-bet mRNA in purified B cells. Up-regulation of T-bet by CpG is abrogated in mice deficient in Toll-like receptor 9 (TLR9) and MyD88, but remains intact in B cells deficient in STAT1 (signal transducer and activator of transcription 1). Interleukin 12 (IL-12) alone does not up-regulate T-bet mRNA, but greatly enhances CpG-induced T-bet expression. Furthermore, CpG inhibits immunoglobulin G1 (IgG1) and IgE switching induced by IL-4 and CD40 signaling in purified B cells, and this effect correlates with up-regulation of T-bet. Thus, CpG triggers anti-allergic immune responses by directly regulating T-bet expression via a signaling pathway in B cells that is dependent upon TLR9, independent of interferon- (IFN-)-STAT1 and synergistic with IL-12.
*Note: In the version of this article initially published online, some of the nomenclature was incorrect. This has been corrected for the HTML and print versions of the article.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
(IFN-
